NCT06948955 2026-03-09
Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors
Cogent Biosciences, Inc.
Available
Cogent Biosciences, Inc.
Karyopharm Therapeutics Inc
USWM, LLC (dba US WorldMeds)
AVM Biotechnology Inc
Agenus Inc.
SpringWorks Therapeutics, Inc.
Advenchen Laboratories, LLC